Clinical Trials on Refractory Hematologic Malignancy in Switzerland
Total 453 results
-
Thomas ZilliUniversity Hospital, GenevaRecruitingHaematological MalignancySwitzerland
-
Centre Hospitalier Universitaire VaudoisUnknownHematologic Diseases | Hematologic Malignancy | Invasive Mold Infections | Breakthrough Invasive Mold InfectionsSwitzerland, Austria, Germany
-
Sequana Medical N.V.CompletedLiver Cirrhosis | Malignant Ascites | Refractory AscitesGermany, Switzerland, Spain, United Kingdom
-
Novartis PharmaceuticalsCompletedHematological MalignanciesGermany, Switzerland, France
-
University of ZurichUniversity Hospital Inselspital, Berne; Swiss Paraplegic Centre Nottwil; Cantonal...Completed
-
University Hospital Inselspital, BerneCompletedColitis | AML | MucositisSwitzerland
-
University Hospital, Basel, SwitzerlandCompletedStatus Epilepticus | Refractory Status EpilepticusSwitzerland
-
University Hospital, Basel, SwitzerlandWithdrawn
-
Onconova Therapeutics, Inc.TerminatedMyelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEBUnited States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
-
Janssen Research & Development, LLCApproved for marketingRelapsed or Refractory Multiple MyelomaBrazil, Germany, Italy, Netherlands, Romania, Switzerland, United Kingdom
-
University Hospital, Basel, SwitzerlandUniversity of Basel; University Hospital, ZürichCompletedHematologic NeoplasmsSwitzerland
-
Rolf InderbitziClinical Trial Unit Ente Ospedaliero CantonaleUnknownMalignant Pleural EffusionSwitzerland
-
University Hospital, Basel, SwitzerlandCompletedFebrile Neutropenia (FN)Switzerland
-
Theusinger Oliver M.Completed
-
University Hospital Inselspital, BerneCompleted
-
University Hospital, Basel, SwitzerlandCompleted
-
European Organisation for Research and Treatment...ETOP IBCSG Partners FoundationCompletedSPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access (SPECTAlung)Any Stage of Lung Cancer (Any Histotype) | Any Stage of Malignant Pleural Mesothelioma | Any Stage of Any Thymic MalignancySpain, Belgium, Ireland, Slovenia, France, United Kingdom, Poland, Italy, Switzerland
-
Swiss Group for Clinical Cancer ResearchCompletedMalignant MesotheliomaSwitzerland
-
Swiss Group for Clinical Cancer ResearchTerminatedRefractory Multiple MyelomaSwitzerland
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingLeukemia | Chronic Lymphocytic Leukemia | Relapsed/Refractory Chronic Lymphocytic LeukemiaSwitzerland
-
Luzerner KantonsspitalRecruitingFunctional Iron DeficiencySwitzerland
-
Centre Hospitalier Universitaire VaudoisCompletedTransfusion ReactionSwitzerland
-
Bristol-Myers SquibbTerminatedCancer | Neoplasm | Tumors | MalignancyUnited States, Canada, Spain, Switzerland
-
Anaveon AGTerminatedHematologic Diseases | Multiple Myeloma | Refractory Multiple Myeloma | Adult Disease | Relapsed CancerSpain, Germany, France, Denmark, Switzerland
-
University of ZurichSwiss National Science Foundation; Swiss Accident Insurance Fund SUVACompletedMalignant Pleural MesotheliomaSwitzerland
-
University of ZurichCompletedDermatologic Disease of Inpatients in Internal MedicineSwitzerland
-
Cristiana SessaCompletedB-cell Lymphoma RefractorySwitzerland
-
Kantonsspital LiestalCompletedBenign or Early Malignant Lesion of the Distal Esophagus or Gastro-esophageal Junction Requiring Surgical ResectionSwitzerland
-
University of ZurichCompletedMalignant Pleural MesotheliomaSwitzerland
-
University Hospital, GenevaCompletedAcquired Platelet DisorderSwitzerland
-
University Hospital, Basel, SwitzerlandCompleted
-
University Hospital, Basel, SwitzerlandRoche Pharma AGCompletedRenal AnemiaSwitzerland
-
Sequana Medical N.V.CompletedMalignant AscitesGermany, Switzerland, United Kingdom
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Waldenstrom Macroglobulinemia | Relapsed/Refractory Richter Transformation | Relapsed/Refractory Burkitt Lymphoma | Relapsed/Refractory Hairy Cell LeukemiaUnited States, Spain, Germany, Italy, France, Netherlands, Switzerland, Austria
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Hoffmann-La RocheCompletedA Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic MelanomaMalignant MelanomaSwitzerland
-
Swiss Federal Institute of TechnologyColumbia UniversityCompletedIron DeficiencySwitzerland
-
Swiss Federal Institute of TechnologyCompleted
-
Swiss Federal Institute of TechnologyDSM Nutritional Products, Inc.Completed
-
Swiss Federal Institute of TechnologyCompleted
-
University Hospital, Basel, SwitzerlandCompletedIron DeficiencySwitzerland
-
Swiss Federal Institute of TechnologyCompleted
-
Swiss Federal Institute of TechnologyCompleted
-
University Hospital, Basel, SwitzerlandRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesSwitzerland
-
Swiss Federal Institute of TechnologyZurich University of Applied SciencesCompleted
-
Swiss Federal Institute of TechnologyCompletedIron-deficiencySwitzerland
-
Isabelle Herter-AeberliBurgerstein VitamineCompletedIron-deficiencySwitzerland
-
Swiss Federal Institute of TechnologyBurgerstein VitamineCompletedIron-deficiencySwitzerland
-
Swiss Federal Institute of TechnologyUnknownIron-deficiencySwitzerland
-
Swiss Federal Institute of TechnologyCompletedIron Deficiency AnemiaSwitzerland